Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen    AMGN

AMGEN

(AMGN)
  Report  
Delayed Quote. Delayed Nasdaq - 12/06 04:00:00 pm
233.77 USD   +0.15%
03:09pAMGEN : Says FDA Approves Avsola for Same Indications as Remicade
DJ
12/03ABARCA : Amgen Enter Outcome-Based Agreement For Enbrel
PR
11/30Novartis Aims to Ace Tough Market -- WSJ
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 22 991 22 849 23 747 23 138 25 132 25 808
EBITDA 13 551 13 613 13 803 13 266 13 896 14 614
Operating profit (EBIT) 11 446 11 658 11 857 11 091 11 900 12 326
Pre-Tax Profit (EBT) 9 163 9 597 9 545 9 535 10 238 12 431
Net income 7 722 1 979 8 394 7 897 8 408 9 289
P/E ratio 14,3x 64,6x 15,4x 18,1x 16,6x 15,0x
EPS ( $ ) 10,2 2,69 12,6 12,9 14,1 15,6
Dividend per Share ( $ ) 4,00 4,60 5,28 5,77 6,19 6,73
Yield 2,74% 2,65% 2,71% 2,47% 2,65% 2,88%
Reference price ( $ ) 146,210 173,900 194,670 233,410 233,410 233,410
Announcement Date 02/02/2017
09:20pm
02/01/2018
09:01pm
01/29/2019
09:01pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - 4 625 13 154 14 323 11 999
Finance 3 489 7 488 - - - -
Operating income (EBITDA) 13 551 13 613 13 803 13 266 13 896 14 614
Leverage
(Debt/EBITDA)
- - 0,34x 0,99x 1,03x 0,82x
Capital Expenditure 738 700 738 669 716 731
Free Cash Flow (FCF) 9 616 9 600 10 558 10 493 10 098 10 920
Book Value Per Share (BVPS) ( $ ) 40,5 35,0 19,8 21,2 24,3 27,7
Cash Flow per Share ( $ ) 13,7 15,2 17,0 14,0 16,0 -
Announcement Date 02/02/2017
09:20pm
02/01/2018
09:01pm
01/29/2019
09:01pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 138 688 M $ -
Entreprise Value (EV) 151 843 M $ 153 011 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 18,1x 16,6x
Capitalization / Revenue 5,99x 5,52x
EV / Revenue 6,56x 6,04x
EV / EBITDA 11,4x 10,9x
Yield (DPS / Price) 2,47% 2,65%
Price to book (Price / BVPS) 11,0x 9,62x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 47,9% 47,3%
Operating Leverage (Delta EBIT / Delta Sales) -2,52x 0,85x
Net Margin (Net Profit / Revenue) 34,1% 33,5%
ROA (Net Profit / Asset) 12,7% 13,4%
ROE (Net Profit / Equities) 71,2% 64,8%
Rate of Dividend 44,8% 44,0%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   2,89% 2,85%
Cash Flow / Sales 36,0% 37,8%
Capital Intensity (Assets / Sales) 2,69x 2,51x
Financial Leverage (Net Debt / EBITDA) 0,99x 1,03x
EPS & Dividend